Michel L. Tremblay

21.8k total citations · 1 hit paper
270 papers, 15.7k citations indexed

About

Michel L. Tremblay is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Michel L. Tremblay has authored 270 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Molecular Biology, 112 papers in Immunology and 42 papers in Oncology. Recurrent topics in Michel L. Tremblay's work include Protein Tyrosine Phosphatases (143 papers), Galectins and Cancer Biology (90 papers) and RNA modifications and cancer (32 papers). Michel L. Tremblay is often cited by papers focused on Protein Tyrosine Phosphatases (143 papers), Galectins and Cancer Biology (90 papers) and RNA modifications and cancer (32 papers). Michel L. Tremblay collaborates with scholars based in Canada, United States and Japan. Michel L. Tremblay's co-authors include Nadia Dubé, Alan Cheng, Noriko Uetani, Matthew Stuible, Serge Hardy, Annie Bourdeau, Jean‐François Côté, C. Jane McGlade, John Wagner and Paul D. Simoncic and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michel L. Tremblay

254 papers receiving 15.4k citations

Hit Papers

The Ity/Lsh/Bcg locus: na... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel L. Tremblay Canada 71 10.4k 5.6k 2.3k 1.8k 1.5k 270 15.7k
Jamey D. Marth United States 69 13.9k 1.3× 6.7k 1.2× 1.9k 0.8× 2.1k 1.1× 1.8k 1.2× 153 19.5k
Peter F. Johnson United States 64 11.2k 1.1× 3.4k 0.6× 2.4k 1.1× 1.3k 0.7× 2.6k 1.8× 127 17.0k
Kjetil Taskén Norway 61 7.4k 0.7× 4.1k 0.7× 2.1k 0.9× 1.0k 0.6× 1.2k 0.8× 288 13.2k
John A. Hanover United States 68 10.6k 1.0× 3.8k 0.7× 1.3k 0.6× 1.7k 0.9× 874 0.6× 209 13.5k
J. Simon C. Arthur United Kingdom 65 10.0k 1.0× 3.5k 0.6× 2.5k 1.1× 2.2k 1.2× 974 0.7× 174 16.2k
Klaus Pfizenmaier Germany 69 7.9k 0.8× 7.5k 1.3× 3.1k 1.3× 1.3k 0.7× 1.0k 0.7× 253 17.3k
Patrick Matthias Switzerland 52 9.3k 0.9× 3.4k 0.6× 2.4k 1.0× 963 0.5× 1.7k 1.1× 109 13.6k
Bing Su United States 59 11.0k 1.1× 5.6k 1.0× 2.7k 1.2× 1.5k 0.8× 1.2k 0.8× 178 17.7k
Len Stephens United Kingdom 67 13.3k 1.3× 3.9k 0.7× 2.1k 0.9× 4.7k 2.5× 889 0.6× 177 19.1k
Perry J. Blackshear United States 85 16.9k 1.6× 3.5k 0.6× 2.4k 1.0× 2.2k 1.2× 1.1k 0.8× 343 22.6k

Countries citing papers authored by Michel L. Tremblay

Since Specialization
Citations

This map shows the geographic impact of Michel L. Tremblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel L. Tremblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel L. Tremblay more than expected).

Fields of papers citing papers by Michel L. Tremblay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel L. Tremblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel L. Tremblay. The network helps show where Michel L. Tremblay may publish in the future.

Co-authorship network of co-authors of Michel L. Tremblay

This figure shows the co-authorship network connecting the top 25 collaborators of Michel L. Tremblay. A scholar is included among the top collaborators of Michel L. Tremblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel L. Tremblay. Michel L. Tremblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez‐Quintero, Luis‐Alberto, Alexandre Poirier, Isabelle Aubry, et al.. (2025). Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition. iScience. 28(10). 113610–113610.
2.
Derieppe, Marie‐Alix, et al.. (2024). PTP4A2 Promotes Glioblastoma Progression and Macrophage Polarization under Microenvironmental Pressure. Cancer Research Communications. 4(7). 1702–1714. 4 indexed citations
3.
Poirier, Alexandre, Isabelle Aubry, Luis‐Alberto Pérez‐Quintero, et al.. (2024). The induction of SHP-1 degradation by TAOK3 ensures the responsiveness of T cells to TCR stimulation. Science Signaling. 17(817). eadg4422–eadg4422. 3 indexed citations
4.
Aubry, Isabelle, et al.. (2024). An HuR mutant, HuR-V225I, identified in adult T-cell Leukemia/Lymphoma, alters the pro-apoptotic function of HuR. Cell Death Discovery. 10(1). 503–503. 1 indexed citations
5.
Papaioannou, Alexandra, Alice Métais, Marion Maurel, et al.. (2022). Stress-induced tyrosine phosphorylation of RtcB modulates IRE1 activity and signaling outputs. Life Science Alliance. 5(5). e202201379–e202201379. 12 indexed citations
6.
Poulet, Mathilde, Jacinthe Sirois, Kevin Boyé, et al.. (2020). PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling. Communications Biology. 3(1). 603–603. 13 indexed citations
7.
Wu, Chia‐Lun, et al.. (2017). Identification of function-regulating antibodies targeting the receptor protein tyrosine phosphatase sigma ectodomain. PLoS ONE. 12(5). e0178489–e0178489. 10 indexed citations
8.
Labbé, David P., Noriko Uetani, Laurent Lessard, et al.. (2016). PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers. Cancer Research. 76(11). 3130–3135. 15 indexed citations
9.
Labbé, David P., Dawid G. Nowak, Geneviève Deblois, et al.. (2013). Prostate Cancer Genetic-susceptibility Locus on Chromosome 20q13 is Amplified and Coupled to Androgen Receptor-regulation in Metastatic Tumors. Molecular Cancer Research. 12(2). 184–189. 7 indexed citations
10.
Chantemèle, Eric J. Belin de, M. Irfan Ali, James Mintz, et al.. (2012). Increasing Peripheral Insulin Sensitivity by Protein Tyrosine Phosphatase 1B Deletion Improves Control of Blood Pressure in Obesity. Hypertension. 60(5). 1273–1279. 22 indexed citations
11.
Lessard, Laurent, David P. Labbé, Geneviève Deblois, et al.. (2012). PTP1B Is an Androgen Receptor–Regulated Phosphatase That Promotes the Progression of Prostate Cancer. Cancer Research. 72(6). 1529–1537. 69 indexed citations
12.
Robert, Françis, John R. Mills, Dantong Wang, et al.. (2011). Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival. Cancer Research. 72(3). 747–756. 30 indexed citations
13.
Hardy, Serge, et al.. (2010). Overexpression of the Protein Tyrosine Phosphatase PRL-2 Correlates with Breast Tumor Formation and Progression. Cancer Research. 70(21). 8959–8967. 54 indexed citations
14.
Gómez, María Adelaida, Irazú Contreras, Maxime Hallé, et al.. (2009). Leishmania GP63 Alters Host Signaling Through Cleavage-Activated Protein Tyrosine Phosphatases. Science Signaling. 2(90). ra58–ra58. 163 indexed citations
15.
Julien, Sofi G., Nadia Dubé, Janice Penney, et al.. (2007). Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nature Genetics. 39(3). 338–346. 258 indexed citations
16.
Tremblay, Michel L.. (1992). La mort de Phèdre. 22–22.
17.
Tremblay, Michel L.. (1986). Le cœur découvert : roman d'amours.
18.
Tremblay, Michel L.. (1984). Des nouvelles d'Édouard. 1 indexed citations
19.
Tremblay, Michel L.. (1984). Hosanna ; La duchesse de Langeais. 1 indexed citations
20.
Tremblay, Michel L.. (1978). La grosse femme d'à côté est enceinte. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026